These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26788820)

  • 21. Incidence and significance of side branch occlusions following bioresorbable scaffold implantation for long left anterior descending artery lesions.
    Tanaka A; Jabbour RJ; Kawamoto H; Chieffo A; Carlino M; Montorfano M; Latib A; Colombo A
    Int J Cardiol; 2016 Nov; 222():674-675. PubMed ID: 27526354
    [No Abstract]   [Full Text] [Related]  

  • 22. Optical coherence tomography of a bifurcation lesion treated with bioresorbable vascular scaffolds with the "mini-crush" technique.
    Costopoulos C; Naganuma T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1326-7. PubMed ID: 24355123
    [No Abstract]   [Full Text] [Related]  

  • 23. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The absorb bioresorbable vascular scaffold in coronary bifurcations: insights from bench testing.
    Džavík V; Colombo A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):81-8. PubMed ID: 24332424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The duration of balloon inflation affects the luminal diameter of coronary segments after bioresorbable vascular scaffolds deployment.
    Sorrentino S; De Rosa S; Ambrosio G; Mongiardo A; Spaccarotella C; Polimeni A; Sabatino J; Torella D; Caiazzo G; Indolfi C
    BMC Cardiovasc Disord; 2015 Dec; 15():169. PubMed ID: 26654975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional optical coherence tomography evaluation of a left main bifurcation lesion treated with ABSORB® bioresorbable vascular scaffold including fenestration and dilatation of the side branch.
    Grundeken MJ; Kraak RP; de Bruin DM; Wykrzykowska JJ
    Int J Cardiol; 2013 Oct; 168(3):e107-8. PubMed ID: 23972365
    [No Abstract]   [Full Text] [Related]  

  • 27. Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis.
    Rivero F; Benedicto A; Bastante T; Cuesta J; Diego G; Alfonso F
    EuroIntervention; 2015 Nov; 11(7):780. PubMed ID: 25308302
    [No Abstract]   [Full Text] [Related]  

  • 28. Why do we need post-dilation after implantation of a bioresorbable vascular scaffold even for a soft lesion?
    Naganuma T; Latib A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1070-2. PubMed ID: 25234682
    [No Abstract]   [Full Text] [Related]  

  • 29. Provisional hybrid 2-stent Strategy utilizing bioresorbable vascular scaffold and drug-eluting metal stent: "T-stenting and small protrusion" technique.
    Miyazaki T; Latib A; Colombo A
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):682-5. PubMed ID: 25510349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A true bifurcational stenosis treated with a bioresorbable vascular scaffold and a drug-eluting metallic stent: Degradable meets durable.
    Wiebe J; Hamm C; Nef H
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1184-8. PubMed ID: 25581885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optical Coherence Tomographic Image Pattern of Metallic Bioresorbable Vascular Scaffold Restenosis.
    Roa-Garrido J; Cardenal-Piris RM; El Amrawy AM; Gomez-Menchero A; Camacho Freire S; Diaz-Fernandez JF
    JACC Cardiovasc Interv; 2018 Apr; 11(7):707-708. PubMed ID: 29550091
    [No Abstract]   [Full Text] [Related]  

  • 32. Culotte Technique With a Bioresorbable Vascular Scaffold: 12 Months' Follow-up.
    Vera Pernasetti L; Gutiérrez H; Ramos B
    Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):973-974. PubMed ID: 27085839
    [No Abstract]   [Full Text] [Related]  

  • 33. Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial.
    Gogas BD; Serruys PW; Diletti R; Farooq V; Brugaletta S; Radu MD; Heo JH; Onuma Y; van Geuns RJ; Regar E; De Bruyne B; Chevalier B; Thuesen L; Smits PC; Dudek D; Koolen J; Windecker S; Whitbourn R; Miquel-Hebert K; Dorange C; Rapoza R; Garcia-Garcia HM; McClean D; Ormiston JA
    JACC Cardiovasc Interv; 2012 Jun; 5(6):656-65. PubMed ID: 22721662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population.
    Costopoulos C; Latib A; Naganuma T; Miyazaki T; Sato K; Figini F; Sticchi A; Carlino M; Chieffo A; Montorfano M; Colombo A
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):E10-5. PubMed ID: 24909303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agreement and reproducibility of gray-scale intravascular ultrasound and optical coherence tomography for the analysis of the bioresorbable vascular scaffold.
    Gómez-Lara J; Brugaletta S; Diletti R; Gogas BD; Farooq V; Onuma Y; Gobbens P; Van Es GA; García-García HM; Serruys PW
    Catheter Cardiovasc Interv; 2012 May; 79(6):890-902. PubMed ID: 21523891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary Artery Aneurysm After Everolimus-Eluting Bioabsorbable Vascular Scaffold Implantation.
    Varghese S; Lauer B; Ohlow MA
    JACC Cardiovasc Interv; 2016 Jan; 9(2):e23-5. PubMed ID: 26793967
    [No Abstract]   [Full Text] [Related]  

  • 37. Vascular Healing of a False Lumen After Bioresorbable Scaffold Implantation.
    Kawamoto H; Jabbour RJ; Tanaka A; Latib A; Colombo A
    Circ Cardiovasc Interv; 2016 Feb; 9(2):e003498. PubMed ID: 26839393
    [No Abstract]   [Full Text] [Related]  

  • 38. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
    Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
    [No Abstract]   [Full Text] [Related]  

  • 39. Current-era biovascular scaffolds seen by experts: An experience-based survey.
    Buccheri D; Valgimigli M; Cortese B
    Int J Cardiol; 2015 Jun; 188():16-8. PubMed ID: 25880574
    [No Abstract]   [Full Text] [Related]  

  • 40. A case of true left main bifurcation treated with bioresorbable everolimus-eluting stent v-stenting.
    Sato K; Latib A; Panoulas VF; Naganuma T; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 Aug; 7(8):e103-4. PubMed ID: 25086841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.